Valuation: BioNexus Gene Lab Corp.

Market Cap 3.72M 3.22M 3M 2.77M 5.22M 354M 5.28M 35.3M 13.85M 177M 13.98M 13.67M 587M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value -91.52K -79.23K -73.83K -67.98K -128K -8.7M -130K -868K -341K -4.35M -344K -336K -14.43M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
64.41%
Yield 2024 *
-
Yield 2025 -
1 week+14.07%
Current month+16.67%
1 month-24.14%
3 months-24.51%
6 months-34.47%
Current year-61.01%
1 week 1.22
Extreme 1.22
1.54
1 month 1.22
Extreme 1.22
2.12
Current year 1.07
Extreme 1.07
4.14
1 year 1.07
Extreme 1.07
6.1
3 years 1.07
Extreme 1.07
33.9
5 years 1.07
Extreme 1.07
270
10 years 1.07
Extreme 1.07
414
Manager TitleAgeSince
Chief Executive Officer 43 2023-12-10
Director of Finance/CFO 63 2025-06-16
Director TitleAgeSince
Director/Board Member 71 2022-03-06
Director/Board Member 43 2023-12-10
Director/Board Member 51 2023-12-10
Date Insider Type Main position Quantity % Market Cap.
7/19/23 Other

Chief Financial Officer

4,797,709 -
7/19/23 Other

Chief Operating Officer

12,500,460 -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+14.07%-76.81%-91.76% 3.72M
+0.90%+0.21%-0.74%+13.87% 48B
+1.98%+7.31%+430.66%+532.17% 41.13B
+3.44%-2.84%+29.17%+8.81% 37.56B
+1.40%-0.89%+7.63%+61.93% 35.91B
+2.42%+7.27%+14.90%+44.79% 29.86B
-0.16%-4.02% - - 16.12B
+2.20%+2.94%+35.92%+127.15% 16.05B
+1.25%+1.69%+4.72%+18.26% 13.76B
+4.25%-9.28%-0.78%-35.46% 12.1B
Average +1.77%-0.52%+49.41%+75.53% 25.05B
Weighted average by Cap. +1.91%-1.29%+85.86%+120.78%

Financials

2024 2025
Net sales 9.51M 8.23M 7.67M 7.07M 13.32M 905M 13.49M 90.18M 35.39M 452M 35.72M 34.93M 1.5B 7.42M 6.43M 5.99M 5.52M 10.4M 706M 10.53M 70.4M 27.63M 353M 27.88M 27.27M 1.17B
Net income -1.6M -1.38M -1.29M -1.19M -2.24M -152M -2.27M -15.15M -5.95M -76.03M -6M -5.87M -252M -2.98M -2.58M -2.41M -2.22M -4.18M -284M -4.23M -28.3M -11.11M -142M -11.21M -10.96M -471M
Net Debt -4.15M -3.59M -3.35M -3.08M -5.81M -395M -5.88M -39.35M -15.44M -197M -15.58M -15.24M -654M -3.81M -3.3M -3.08M -2.83M -5.34M -363M -5.41M -36.16M -14.19M -181M -14.32M -14.01M -601M
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
26-08-05 US$1.540 0.00% 4,050
26-08-04 US$1.540 +7.69% 8,710
26-08-03 US$1.430 +8.33% 108,915
26-07-31 US$1.320 0.00% 10,006
26-07-30 US$1.320 -2.94% 3,567
  1. Stock Market
  2. Stocks
  3. BGLC Stock